HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) All Versions of this Article: thx.2006.063065v1 62/3/248    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Davies, S. J Articles by Nicholson, A. G Search for Related Content PubMed PubMed Citation Articles by Davies, S. J Articles by Nicholson, A. G Topic Collections Relevant Article

Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: an under-recognised spectrum of disease

¹ Department of Histopathology, Royal Brompton and Harefield Hospitals NHS Trust, London, UK
² Department of Radiology, Royal Brompton and Harefield Hospitals NHS Trust, London, UK
³ Department of Respiratory Medicine, Royal Brompton and Harefield Hospitals NHS Trust, London, UK
⁴ Department of Histopathology, Royal Liverpool University Hospital, Liverpool, UK

Correspondence to:
Correspondence to:
Professor A G Nicholson
Department of Histopathology, Royal Brompton Hospital, Sydney Street, London SW3 6NP, UK; a.nicholson{at}rbht.nhs.uk

ABSTRACT
Aims and Methods: A review was undertaken of 19 patients diagnosed with diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH) between 1992 and 2006.

Results: Most patients were women (n = 15) and non-smokers (n = 16). Clinical presentation was either with symptomatic pulmonary disease (group 1; n = 9) or as an incidental finding during investigation for another disorder, most frequently malignant disease (group 2; n = 10). In group 1, cough and dyspnoea were the most frequent symptoms, with an average duration of 8.6 years before diagnosis. Both groups showed mainly stable disease without treatment, although one patient progressed to severe airflow obstruction and one was diagnosed at single lung transplantation. Mosaicism with nodule(s) was the typical pattern of DIPNECH on high-resolution computed tomography, but one case had normal imaging despite airflow obstruction. Lung function tests showed obstructive (n = 8), mixed (n = 3) or normal (n = 5, all group 2) physiology. Two patients underwent a bronchoalveolar lavage and showed a lymphocytosis (30%) with mild chronic bronchiolitis being seen in all biopsies. Tumourlets and associated typical carcinoids (n = 9) showed weak positivity for thyroid transcription factor-1. Three patients had atypical carcinoids, one with multiple endocrine neoplasia type 1 syndrome.

Conclusions: DIPNECH is being increasingly recognised, probably because of an increase in the usage and accuracy of investigative imaging and increased awareness of the entity. Most cases remain stable over many years independent of the mode of presentation, although a few patients progress to severe airflow obstruction.

Abbreviations: DIPNECH, diffuse idiopathic pulmonary neuroendocrine cell hyperplasia; HRCT, high-resolution computed tomography; MEN, multiple endocrine neoplasia

Relevant Article

Airwaves

Wisia Wedzicha
Thorax 2007 62: 193. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

				G. H. Deutsch, L. R. Young, R. R. Deterding, L. L. Fan, S. D. Dell, J. A. Bean, A. S. Brody, L. M. Nogee, B. C. Trapnell, C. Langston, et al. Diffuse Lung Disease in Young Children: Application of a Novel Classification Scheme Am. J. Respir. Crit. Care Med., December 1, 2007; 176(11): 1120 - 1128. [Abstract] [Full Text] [PDF]